Parkinson's disease: Premotor clinico-pathological correlations

Journal of Neural Transmission, Supplement

Volumn , Issue 70, 2006, Pages 309-319

  Wolters, E Ch ^a   Braak, H ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SYNUCLEIN;

AKINESIA; BRADYKINESIA; CONFERENCE PAPER; DEMENTIA; DEPRESSION; DISEASE CLASSIFICATION; DISEASE COURSE; HUMAN; HYPOKINESIA; LEWY BODY; MUSCLE RIGIDITY; NERVE CELL; NERVE DEGENERATION; NEUROPHYSIOLOGY; PAIN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; SLEEP DISORDER; SMELLING DISORDER; TREMOR;

EID: 33750351505     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-211-45295-0_47     Document Type: Conference Paper

References (59)

1. Amino T, Orimo S, Itoh Y, Takahashi A, Uchihara T, Mizusawa H (2005) Profound cardiac sympathetic denervation occurs in Parkinson disease. Brain Pathol 15: 29-34
2. Arnulf I, Konofal E, Merino-Andreu M, Houeto JL, Mesnage V, Welter ML, Lacomblenz L, Golmard JL, Derenne JP, Agid Y (2002) Parkinson's disease and sleepiness: an integral part of PD. Neurology 58: 1019-1024
3. Berendse HW, Booij J, Francot Ch, Bergmans PLM, Hijman R, Stoof JC, Wolters ECh (2001) Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell. Ann Neurol 50: 34-41
4. Bonuccelli U, Lucetti C, Del Dotto P, Ceravolo R, Gambaccini G, Bernardini S, Rossi G, Piaggesi A (2003) Orthostatic hypotension in de novo Parkinson disease. Arch Neurol 60: 1400-1404
5. Booij J, Tissingh G, Winogrodzka A, van Royen EA et al. (1999) Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism. Eur J Nucl Med 26: 171-182
6. Bosboom H, Stoffers D, Wolters ECh (2004) Cognitive function in Parkinson's disease. J Neural Transm 111: 1303-1315
7. Braak H, Braak E (2000) Pathoanatomy of Parkinson's disease. J Neurol 247 [Suppl 2]: S3-S10
8. Braak H, Del Tredici K, Rueb U, de Vos RAI, Jansen Steur ENH, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24: 197-211
9. Braak H, Rub U, Gai WP, Del Tredici K (2003) Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110: 517-536
10. Braak H, Ghebremedhin E, Rueb U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 318: 121-134
11. Braak H, Rub U, Jansen Steur EN, Del Tredici K, de Vos RA (2005) Cognitive status correlates with neuropathologic stage in Parkinson's disease. Neurology 64: 1404-1410
12. Bronner G, Royter V, Korczyn AD, Giladi N (2004) Sexual dysfunction in Parkinson's disease. J Sex Marital Ther 30: 95-105
13. Brown RG, Soliveri P, Jahanshahi M (1998) Executive processes in Parkinson's disease - random number generation and response suppression. Neuropsychol 36: 1355-1362
14. Calne D (2005) A definition of Parkinson's disease. J Parkinsonism Relat Disord 1: S39-S40
15. Chaudhuri KR, Yates L, Martinez-Martin P (2005) The Non-motor symptom complex of Parkinson's disease: a comprehensive assessment is essential. Curr Neurol Neurosci Rep 5: 275-283
16. Cummings JL (2004) Dementia with lewy bodies: molecular pathogenesis and implications for classification. J Geriatr Psychiatry Neurol 17: 112-119
17. Del Tredici K, Rub U, De Vos RA, Bohl JR, Braak H (2002) Where does parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61: 413-426
18. Dubois B, Pillon B (1997) Cognitive deficits in Parkinson's disease. J Neurol 244: 2-8
19. Fantini ML, Ferini-Strambi L, Montplaisir J (2005) Idiopathic REM sleep behavior disorder: toward a better nosologic definition. Neurology 64:780-786
20. Fearnley JM, Lees AJ (1991) Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114: 2283-2301
21. Giuffrida R, Vingerhoets FJ, Bogousslavsky J, Ghika J (2005) Pain in Parkinson's disease. Rev Neurol (Paris) 161: 407-418
22. Gonera EG, van't Hof M, Berger HJ, van Weel C, Horstink MW (1997) Symptoms and duration of the prodromal phase in Parkinson's disease. Mov Disord 12: 871-876
23. Hague K, Lento P, Morgello S, Caro S, Kaufmann H (1997) The distribution of Lewy bodies in pure autonomie failure: autopsy findings and review of the literature. Acta Neuropathol (Berl) 94: 192-196
24. Hocherman S, Giladi N (1998) Visuomotor control abnormalities in patients with unilateral parkinsonism. Neurology 50: 1648-1654
25. Huisman E, Uylings HB, Hoogland PV (2004) A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease. Mov Disord 19: 687-692
26. Iwanaga K, Wakabayashi K, Yoshimoto M, Tomita I, Satoh H, Takashima H, Satoh A, Seto M, Tsujihata M, Takahashi H (1999) Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases. Neurology 52: 1269-1271
27. Jellinger KA (1999) Post mortem studies in Parkinson's disease-is it possible to detect brain areas for specific symptoms? J Neural Transm 56: 1-29
28. Kaufmann H, Nahm K, Purohit D, Wolfe D (2004) Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies. Neurology 63: 953-954
29. Koller WC (1998) Neuroprotection for Parkinson's disease. Ann Neurol 44 [Suppl 1]: S155-S159
30. Larner AJ, Mathias CJ, Rossor MN (2000) Autonomic failure preceding dementia with Lewy bodies. J Neurol 247: 229-231
31. Lewis SJG, Foltynie T, Blackwell AD, Robbins TW, Owen AM, Barker RA (2005) Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 76: 343-348
32. Magerkurth C, Schnitzer R, Braune S (2005) Symptoms of autonomic failure in Parkinson's disease: prevalence and impact on daily life. Clin Auton Res 15: 76-82
33. Mahieux F, Fenelon G, Flahault A, Manifacier MJ, Michelet D, Boiler F (1998) Neuropsychological prediction of dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 64: 178-183
34. Marek K, Innis R, van Dyck C, Fussell B, Early M, Eberly S, Oakes D, Seybil J (2001)[(123)I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression. Neurology 57: 2089-2094
35. Micieli G, Tosi P, Marcheselli S, Cavallini A (2003) Autonomic dysfunction in Parkinson's disease. Neurol Sci 24 [Suppl 1]: S32-S34
36. Montgomery EB, Baker KB, Lyons K, Koller W (1999) Abnormal performance on the PD test battery by asymptomatic first degree relatives. Neurology 52: 757-762
37. Morris RG, Downes JJ, Sahakian BJ, Evenden JL, Heald A, Robbins TW (1988) Planning and spatial working memory in Parkinson's disease. J Neurol Neurosurg Psychiatry 51: 757-766
38. Morrish PK, Rakshi JS, Bailey DL, Sawle GV, Brooks DJ (1998) Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET. J Neurol Neurosurg Psychiatry 64: 314-319
39. Oppenheimer DR (1980) Lateral horn cells in progressive autonomic failure. J Neurol Sci 46: 393-404
40. Pacchetti C, Manni R, Zangaglia R, Mancini F, Marchioni E, Tassorelli C, Terzaghi M, Ossola M, Martignoni E, Moglia A, Nappi G (2005) Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease. Mov Disord, October 14 (Epub ahead of print)
41. Ponsen MM, Stoffers D, Booij J, van Eck-Smit BLF, Wolters ECh, Berendse HW (2004) Idiopatic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 56: 173-181
42. Przuntek H, Muller T, Riederer P (2004) Diagnostic staging of Parkinson's disease: conceptual aspects. J Neural Transm 111: 201-216
43. Remy P, Doder M, Lees A, Turjanski N, Brooks D (2005) Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 128: 1314-1322
44. Sage JI, Mark MH (1995) Drenching sweats as an off phenomenon in Parkinson's disease: treatment and relation to plasma levodopa profile. Ann Neurol 37: 120-122
45. Schenck CH, Bundlie SR, Mahowald MW (1996) Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic REM sleep disorder behavior. Neurology 46: 388-393
46. Scherder E, Wolters E, Polman C, Sergeant J, Swaab D (2005) Pain in Parkinson's disease and multiple sclerosis: its relation to the medial and lateral pain systems. Neurosci Biobehav Rev 29: 1047-1056
47. Schuurman AG, van den Akker M, Ensinck KTJL, Metsemakers JF, Knottnerus JA, Leentjens AF, Buntix F (2002) Increased risk of Parkinson's disease after depression: a retrospective cohort study. Neurology 58: 1501-1504
48. Simard M, van Reekum R, Cohen T (2000) A review of the cognitive and behavioral symptoms in dementia with Lewy bodies. J Neuropsychiatry Clin Neurosci 12: 425-450
49. Singleton A, Gwinn-Hardy K, Sharabi Y, Li ST, Holmes C, Dendi R, Hardy J, Singleton A, Crawley A, Goldstein DS (2004) Association between cardiac denervation and parkinsonism caused by alpha-synuclein gene triplication. Brain 127: 768-772
50. Soler JM, Le Portz B (2004) Bladder sphincter disorders in Parkinson's disease Ann Urol (Paris) 38 [Suppl 2]: S57-S61
51. Stiasny-Kolster K, Doerr Y, Moller JC, Hoffken H, Behr TM, Oertel WH, Mayer G (2005) Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 128: 126-137
52. Stoffers D, Berendse HW, Deijen JB, Wolters ECh (2001) Motor perseveration is an early sign in Parkinson's disease. Neurology 57: 2111-2113
53. Tissingh G, Bergmans P, Booij J, Winogrodzka A, van Royen EA, Stoof JC, Wolters EC (1998) Drug-naive patients with Parkinson's disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]beta-CIT SPECT. J Neurol 245: 14-20
54. Tissingh G, Booij J, Bergmans P et al. (1998) Iodine-123-N-omega- fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease. J Nucl Med 39: 1143-1148
55. Tissingh G, de Waard R, Bergmans P, Drukarch B, Stoof JC, Wolters ECh (2001) Loss of olfactory discrimination in de-novo Parkinson's disease patients. Mov Disord 16: 41-46
56. Uitti RJ, Baba Y, Wszolek ZK, Putzke DJ (2005) Denning the Parkinson disease phenotype: initial symptoms and baseline characteristics in a clinical cohort. J Parkinsonism Relat Disord 11: 139-145
57. Vanderhaeghen JJ, Perier O, Sternon JE (1970) Pathological findings in idiopathic orthostatic hypotension: its relationship with Parkinson's disease. Arch Neurol 22: 207-214
58. Waxman MJ, Durfee D, Moore M, Morantz RA, Koller W (1990) Nutritional aspects and swallowing function of patients with Parkinson's disease. Nutr Clin Pract 5: 196-199
59. Yu M, Roane DM, Miner CR, Fleming M, Rogers JD (2004) Dimensions of sexual dysfunction in Parkinson's disease. Am J Geratr Psychiatry 12: 221-226